Factors Affecting Neutrophil Recovery After Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Acute Myeloid Leukemia

Transplantation Proceedings

Volumn 41, Issue 9, 2009, Pages 3868-3872

  Kozlowska Skrzypczak, M ^a   Gil, L ^a   Komarnicki, M ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; COLONY FORMING UNIT GM; ENGRAFTMENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUTROPHIL; PRIORITY JOURNAL; PROBABILITY; REMISSION; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; FEMALE; GRANULOCYTE-MACROPHAGE PROGENITOR CELLS; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; LEUKEMIA, MYELOID, ACUTE; MACROPHAGES; MALE; MIDDLE AGED; NEUTROPENIA; NEUTROPHILS; SHOCK, SEPTIC; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 71749120985     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.191     Document Type: Article

References (15)

1. Harousseau J.L., Cahn J.Y., Pignon B., et al. Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM). Blood 90 (1997) 2978
2. Burnett A.K., Goldstone A.H., Stevens R.M., et al. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties. Lancet 351 (1998) 700
3. Levi I., Grotto I., Yerushalmi R., et al. Meta-analysis of autologous bone marrow transplantation versus chemotherapy in adult patients with acute myeloid leukemia in first remission. Leuk Res 28 (2004) 605
4. Vey N., Bouabdallah R., Stoppa A., et al. Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution. Bone Marrow Transplant 33 (2004) 177
5. Gorin N.C., Labopin M., Blaise D., et al. Higher incidence of relapse with peripheral blood as source of stem cells in adult patients with acute myelocytic leukaemia autografted in first remission. Bone Marrow Transplant 41 (2008) S13
6. Gil L., Kozlowska-Skrzypczak M., Mol A., et al. Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT. Bone Marrow Transplant 43 (2009) 121
7. Gil L., Styczynski J., and Komarnicki M. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome. Infection 35 (2007) 421
8. Giles F.J., Keating A., Goldstone A.H., et al. Acute myeloid leukemia. Hematology Am Soc Hematol Educ Program (2002) 73
9. Lowenthal R.M., Faberes C., Marit G., et al. Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience. Bone Marrow Transplant 22 (1998) 763
10. Sutherland H.J., Eaves C.J., Lansdorp P.M., et al. Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants. Blood 83 (1994) 3808
11. Bensinger W.I., Longin K., Appelbaum F., et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87 (1994) 825
12. Strodtbeck D., Bornhauser M., Hanel M., et al. Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission. Bone Marrow Transplant 36 (2005) 1083
13. Keating S., Suciu S., de Witte T., et al. The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial. Leukemia 17 (2003) 60
14. Feller N., Schuurhuis G.J., van der Pol M.A., et al. High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome. Leukemia 17 (2003) 68
15. Mehta J., Powles R., Horton C., et al. Factors affecting engraftment and hematopoietic recovery after unpurged autografting in acute leukemia. Bone Marrow Transplant 18 (1996) 319